Quote:
Originally posted by AKA_Monet
Most researchers want to introduce "therapeutic genes" into folks that have diseases: such as diabetes, heart disease and cancer. However, ES cell technology in mice have proven to be much harder to develop that one had anticipated. And straight out cloning is not working that well either. Besides it is not worth it.
Then nobody wants to be reminded of the huge fiasco that occured with gene therapy in the mid-1990s...
|
I worked for 2 summers in a lab doing gene therapy research, primarily with regard to cancer - the research is amazingly promising, and has been for years, but the process is painstaking and brutally slow. Our work with mice showed successes, failures, and really any intermediate you can imagine - as for not worth it, though . . . are you referring specifically to cloning?
Otherwise - we always felt the research, along w/ Stem cell actions, was honestly the best cutting-edge use of funding (which I'm sure you know, is 90% of research, unfortunately).
I'll PM you w/ specifics if you're down, but I'm still bound by my NDA.
Hybrid Mode
